Clinical Study
Exposure to Ti4Al4V Titanium Alloy Leads to Redox Abnormalities, Oxidative Stress, and Oxidative Damage in Patients Treated for Mandible Fractures
Table 4
Correlations of redox biomarkers in control group and patients with titanium mandibular fixations.
| | | | |
| Control group | TOS Man | OSI Man | 0.551 | 0.033 | TAC Man | UA plasma | 0.425 | 0.043 | GPx erythrocytes | FRAP plasma | 0.737 | 0.037 | TAC plasma | GSH plasma | 0.608 | 0.003 | 8-OHdG plasma | AOPP plasma | 0.559 | 0.047 | Study group | UA Man | FRAP Man | 0.519 | 0.019 | TAC Man | AGE Man | 0.450 | 0.031 | 4-HNE Man | OSI Man | 0.592 | 0.043 | 8-OHdG Man | AGE Man | 0.883 | 0.000 | TOS Man | OSI Man | 0.567 | 0.034 | AGE Man | GPx erythrocytes | 0.574 | 0.025 | TOS Man | CAT erythrocytes | 0.515 | 0.043 | 8-OHdG Man | GPx erythrocytes | 0.781 | 0.002 | TAC Man | UA plasma | 0.425 | 0.043 | 4-HNE Man | GSH plasma | 0.662 | 0.019 | GSH Man | GSH plasma | 0.417 | 0.048 | SOD erythrocytes | AGE plasma | 0.470 | 0.020 | TAC plasma | AOPP plasma | 0.695 | 0.000 | TOS plasma | AOPP plasma | 0.529 | 0.000 | TOS plasma | GSH plasma | 0.645 | 0.002 | 8-OHdG plasma | GSH plasma | 0.589 | 0.044 |
|
|
4-HNE: 4-hydroxynonenal protein adducts; 8-OHdG: 8-hydroxydeoxyguanosine; AGE: advanced glycation end products; AOPP: advanced oxidation protein products; CAT: catalase; FRAP: ferric reducing ability of plasma; GPx: glutathione peroxidase; GSH: reduced glutathione; Man: mandible; OSI: oxidative stress index; SOD: superoxide dismutase-1; TAC: total antioxidant status; TOS: total oxidant status; UA: uric acid.
|